The U.S. Food and Drug Administration approved British drugmaker GSK's combination vaccine to protect against meningococcal ...

After calling Rockville, Maryland, home for more than eight years, GSK's vaccine and infectious disease R&D teams are ...

The incoming employees at the biopharmaceutical giant will zero in on mRNA, structural biology, and viral vaccine research ...

Rockville’s MaxCyte has made its first acquisition in its more than quarter-century of operation. It’s keeping its eyes out ...

MaxiVision, the south India’s eye care hospital chain led by industry veteran GSK Velu, is now eyeing expansion in western ...

Ben & Jerry's maker Unilever has chosen Amsterdam over London and New York as the primary listing for its ice cream business, ...

Maxivision Super Specialty Eye Hospitals has partnered with Ojas Group of Eye Hospitals to expand operations in Maharashtra.

Investment platform AJ Bell has released its January list of most popular ISA investments among do-it-yourself (DIY) investors - here are the findings.

Royalty Pharma has signed a deal to pay Biogen $250m to support the development of its late-stage experimental lupus ...

Hanon meanwhile is joined at Vicebio by two other ex-GSK staffers – Dr Giovanni Della Cioppa and Dr Jean Smal – who will serve as chief medical officer and chief technology officer ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...